Repurposed drugs
Showing 9976 - 10000 of >10,000
Diabetes, Diabetes, Type 2 Trial in Russian Federation (biphasic insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- biphasic insulin aspart
-
Arkhangelsk, Russian Federation
- +10 more
Jan 5, 2017
Tocilizumab (RoActemra/Actemra) in Rheumatoid Arthritis
Completed
- Rheumatoid Arthritis
-
Hospitalet de Llobregat, Barcelona, Spain
- +15 more
Sep 8, 2016
Head Neck Cancer Trial in Miami (cisplatin, cytochlor, tetrahydrouridine)
Completed
- Head and Neck Cancer
- cisplatin
- +3 more
-
Miami, FloridaUniversity of Miami Sylvester Comprehensive Cancer Center
Dec 14, 2016
Pharmacodynamics of Ceftazidime in Pediatric ICU Patients
Unknown status
- Sepsis
-
Chicago, IllinoisAnn & Robert H Lurie Childjren's Hospital of Chicago
Apr 25, 2017
Low Lymphocyte Count in Patients With Type 2 Diabetes
Completed
- Diabetes Mellitus, Type 2
- (no location specified)
Nov 30, 2016
Malaria, HIV Trial in Kampala (Dolutegravir 50mg od, Artemether-lumefantrine combination, Artesunate-amodiaquine)
Completed
- Malaria
- HIV
- Dolutegravir 50mg od
- +2 more
-
Kampala, UgandaInfectious Diseases Institute
Oct 4, 2016
HIV Infection Trial in Philadelphia (Rifampicin 600 mg)
Completed
- HIV Infection
- Rifampicin 600 mg
-
Philadelphia, PennsylvaniaDrexel University College of Medicine
Feb 28, 2017
Nonsmall Cell Lung Cancer Trial in Beijing (Apatinib Mesylate Tablets, EGFR-TKIs (Erlotinib, Gefitinib and Osimertinib))
Unknown status
- Nonsmall Cell Lung Cancer
- Apatinib Mesylate Tablets
- EGFR-TKIs (Erlotinib, Gefitinib and Osimertinib)
-
Beijing, Beijing, ChinaPeking University Third Hospital
Feb 9, 2017
Ventricular Tachycardia Trial in Portland (MRI guided VT ablation, Increased dose of amiodarone)
Withdrawn
- Ventricular Tachycardia
- MRI guided VT ablation
- Increased dose of amiodarone
-
Portland, OregonOregon Health & Science University
May 9, 2017
Squamous Cell Carcinoma of the Head and Neck (SCCHN) Trial in Boston (Bevacizumab, erlotinib, Sulindac)
Terminated
- Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- Bevacizumab
- +2 more
-
Boston, Massachusetts
- +1 more
Mar 15, 2017
Unresectable and Advanced Cholangiocarcinoma Trial in France (Sunitinib)
Completed
- Unresectable and Advanced Cholangiocarcinoma
-
Clichy, France
- +5 more
Jan 30, 2017
Healthy Trial in Vienna (Timoptic® 0.5%, Timophtal sine® 0.5%, Genteal HA®)
Terminated
- Healthy
- Timoptic® 0.5%
- +4 more
-
Vienna, AustriaDepartment of Clinical Pharmacology, Medical University of Vienn
Dec 1, 2016
Opioid-Related Disorders Trial in Baltimore (Tramadol, Naloxone, Morphine)
Completed
- Opioid-Related Disorders
- Tramadol
- +2 more
-
Baltimore, MarylandJohns Hopkins University (BPRU) Bayview Campus
Jan 11, 2017
Automatic Versus Evaluative Components of Cue Reactivity
Completed
- Drug Dependence
-
Baltimore, MarylandNational Institute on Drug Abuse, Biomedical Research Center (BR
Jun 30, 2017
PET Imaging of Nicotinic Acetylcholine Receptors
Completed
- Healthy Volunteers
- +2 more
-
Baltimore, MarylandNational Institute on Drug Abuse, Biomedical Research Center (BR
Jun 30, 2017
Ovarian Function, Preservation of Ovarian Function Trial run by the NICHD (GnRH antagonist)
Withdrawn
- Ovarian Function
- Preservation of Ovarian Function
- GnRH antagonist
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Smoldering Multiple Myeloma Trial in Cleveland (celecoxib,
Completed
- Monoclonal Gammopathy of Undetermined Significance
- +2 more
- celecoxib
- +2 more
-
Cleveland, OhioCleveland Clinic Foundation
Dec 28, 2016
NSCLC Trial in Boston (erlotinib, hydroxychloroquine)
Terminated
- Non-small Cell Lung Cancer
-
Boston, MassachusettsMassachusetts General Hospital
Jan 27, 2017
Marijuana Abuse Trial in New York (Nefazodone, Bupropion)
Completed
- Marijuana Abuse
-
New York, New YorkNew York State Psychiatric Institute
Jan 13, 2017
Acute Lymphoblastic Leukemia Trial in Boston (Corticosteroid, Rapamycin)
Completed
- Acute Lymphoblastic Leukemia
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 21, 2016
Hepatocellular Carcinoma Trial (TACE and Apatinib, TACE)
Unknown status
- Hepatocellular Carcinoma
- TACE and Apatinib
- TACE
- (no location specified)
Feb 23, 2017
Diabetes, Type 2, Onychomycosis Trial in Vancouver (Laser Treatment YAG laser, Standard Treatment (control group) terbinafine
Unknown status
- Diabetes Mellitus, Type 2
- Onychomycosis
- Laser Treatment YAG laser
- Standard Treatment (control group) terbinafine hydrochloride tablets
-
Vancouver, British Columbia, CanadaDiamond Centre
Feb 16, 2017
Multiple Myeloma Trial in Boston (dexamethasone, lenalidomide, melphalan)
Completed
- Multiple Myeloma
- dexamethasone
- +2 more
-
Boston, MassachusettsBoston University Cancer Research Center
Dec 28, 2016